CDTX
Price
$48.78
Change
+$0.91 (+1.90%)
Updated
Jul 3 closing price
Capitalization
1.02B
DBVT
Price
$11.60
Change
+$1.30 (+12.62%)
Updated
Jul 3 closing price
Capitalization
295.51M
Interact to see
Advertisement

CDTX vs DBVT

Header iconCDTX vs DBVT Comparison
Open Charts CDTX vs DBVTBanner chart's image
Cidara Therapeutics
Price$48.78
Change+$0.91 (+1.90%)
Volume$412.73K
Capitalization1.02B
DBV Technologies S.A
Price$11.60
Change+$1.30 (+12.62%)
Volume$29.06K
Capitalization295.51M
CDTX vs DBVT Comparison Chart in %
Loading...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DBVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDTX vs. DBVT commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDTX is a Hold and DBVT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (CDTX: $48.78 vs. DBVT: $11.60)
Brand notoriety: CDTX and DBVT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDTX: 64% vs. DBVT: 49%
Market capitalization -- CDTX: $1.02B vs. DBVT: $295.51M
CDTX [@Biotechnology] is valued at $1.02B. DBVT’s [@Biotechnology] market capitalization is $295.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDTX’s FA Score shows that 0 FA rating(s) are green whileDBVT’s FA Score has 0 green FA rating(s).

  • CDTX’s FA Score: 0 green, 5 red.
  • DBVT’s FA Score: 0 green, 5 red.
According to our system of comparison, both CDTX and DBVT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDTX’s TA Score shows that 4 TA indicator(s) are bullish while DBVT’s TA Score has 6 bullish TA indicator(s).

  • CDTX’s TA Score: 4 bullish, 4 bearish.
  • DBVT’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, DBVT is a better buy in the short-term than CDTX.

Price Growth

CDTX (@Biotechnology) experienced а +1.56% price change this week, while DBVT (@Biotechnology) price change was +25.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDTX($1.02B) has a higher market cap than DBVT($296M). DBVT YTD gains are higher at: 275.405 vs. CDTX (81.473). DBVT has higher annual earnings (EBITDA): -107.89M vs. CDTX (-192.6M). CDTX has more cash in the bank: 168M vs. DBVT (13M). CDTX has less debt than DBVT: CDTX (2.67M) vs DBVT (7.51M). CDTX has higher revenues than DBVT: CDTX (302K) vs DBVT (0).
CDTXDBVTCDTX / DBVT
Capitalization1.02B296M345%
EBITDA-192.6M-107.89M179%
Gain YTD81.473275.40530%
P/E RatioN/AN/A-
Revenue302K0-
Total Cash168M13M1,292%
Total Debt2.67M7.51M36%
FUNDAMENTALS RATINGS
CDTX vs DBVT: Fundamental Ratings
CDTX
DBVT
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
93
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
3434
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CDTX's Valuation (86) in the Biotechnology industry is in the same range as DBVT (93). This means that CDTX’s stock grew similarly to DBVT’s over the last 12 months.

CDTX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as DBVT (100). This means that CDTX’s stock grew similarly to DBVT’s over the last 12 months.

DBVT's SMR Rating (99) in the Biotechnology industry is in the same range as CDTX (100). This means that DBVT’s stock grew similarly to CDTX’s over the last 12 months.

DBVT's Price Growth Rating (34) in the Biotechnology industry is in the same range as CDTX (34). This means that DBVT’s stock grew similarly to CDTX’s over the last 12 months.

DBVT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as CDTX (100). This means that DBVT’s stock grew similarly to CDTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CDTXDBVT
RSI
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
86%
Momentum
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 5 days ago
81%
MACD
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 5 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 5 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
77%
Advances
ODDS (%)
Bullish Trend 28 days ago
85%
Bullish Trend 12 days ago
80%
Declines
ODDS (%)
Bearish Trend 18 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 5 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DBVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
URNQX56.410.56
+1.00%
Victory Nasdaq 100 Index R6
ADNRX19.580.18
+0.93%
American Beacon ARK Transfmt Innov R6
USRTX32.740.27
+0.83%
Horizon Multi-Factor U.S. Equity Advisor
BIEEX18.380.14
+0.77%
BlackRock GA Dynamic Eq Instl
RYBMX75.080.01
+0.01%
Rydex Basic Materials A

CDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDTX has been closely correlated with WINT. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDTX jumps, then WINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDTX
1D Price
Change %
CDTX100%
+1.90%
WINT - CDTX
94%
Closely correlated
+20.68%
NBY - CDTX
93%
Closely correlated
+0.62%
NCNA - CDTX
93%
Closely correlated
-5.13%
TAOX - CDTX
93%
Closely correlated
+5.20%
BPTSY - CDTX
92%
Closely correlated
N/A
More

DBVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, DBVT has been closely correlated with WINT. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if DBVT jumps, then WINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DBVT
1D Price
Change %
DBVT100%
+12.62%
WINT - DBVT
78%
Closely correlated
+20.68%
NCNA - DBVT
77%
Closely correlated
-5.13%
CDTX - DBVT
77%
Closely correlated
+1.90%
TAOX - DBVT
75%
Closely correlated
+5.20%
RNAC - DBVT
74%
Closely correlated
-1.41%
More